QL-1200186
Based on 1 Customer Validation
QL-1200186 is a selective, orally active, allosteric inhibitor targeting the tyrosine kinase TYK2 pseudokinase domain JH2 (IC50=0.06 nM, TYK2 JH2), with 164-fold selectivity over TYK1 JH2 (IC50=9.85 nM，TYK1 JH2). QL-1200186 first stabilizes the TYK2 JH2 conformation, inhibits the activity of the JH1 catalytic domain, and blocks the IFNα, IL-12/IL-23-mediated JAK-STAT signaling pathway. QL-1200186 can inhibit the production of Th1/Th17 cell-related cytokines (such as IFNγ, IL-23), reduce immune cell activation, and has no significant effect on JAK1/2/3 kinase activity. QL-1200186 can significantly improve skin inflammation in the Imiquimod (HY-B0180)-induced psoriasis mouse model and reduce the Psoriasis Area and Severity Index (PASI) score. QL-1200186 can be used in the study of autoimmune diseases such as psoriasis and systemic lupus erythematosus (SLE).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.95%
- CAS No.: 2848664-42-4
- 화학식: C26H27N7O3
- 분자량:485.54
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
Biological Activity
제품 설명
IC50 & Target
|
IL-12 |
IL-23 |
STAT1 |
STAT3 |
STAT5 |
In Vitro
QL-1200186 (1-10 μM; 30 min+15 min) inhibits IFNα-induced STAT1 phosphorylation (pSTAT1) in CD3+ T cells with an IC50 of 1.61 nM; in NK-92 cells and Th17 cells, the IC50s for IL-12-induced IFN-γ expression and IL-23-induced pSTAT3 are 32.48 nM and 1.026 nM, respectively[1].
QL-1200186 (1-10 μM; 48 h) inhibits IFNα-induced pSTAT5 in human PBMCs with an IC50 of 7.26 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293 cells engineered to express human TYK2
-
Concentration:0.001, 0.01, 0.1, 1, 10 μM
-
Incubation Time:1 h
-
Result:Dose-dependently inhibited TYK2 autophosphorylation with an IC50 of 0.06 nM.
Reduced phosphorylation of TYK2 and downstream STAT proteins.
No significant inhibition of JAK1/2/3 was observed at concentrations up to 10 μM.
Parmacokinetics
In Vivo
QL-1200186 (5-30 mg/kg; oral; twice daily; 7 dayss) significantly reduces PASI scores and improves skin erythema, scaling and thickening in an Imiquimod (HY-B0180)-induced mouse psoriasis model, with skin thickness reduced by 49.7% in the 30 mg/kg group[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male BALB/c mice (18-20 g, 6-8 weeks) with Imiquimod-induced psoriasis-like dermatitis[1]
-
Dosage:5, 10, 30 mg/kg
-
Administration:Oral gavage, twice daily for 7 days, concurrent with daily Imiquimod application (daily topical dose of 62.5 mg of 5% Imiquimod cream)
-
Result:Significantly lowered PASI scores in treatment groups compared to vehicle control.
Showed a 49.7% reduction in skin thickness, with decreased epidermal hyperplasia and immune cell infiltration observed by histopathology, at 30 mg/kg group.
Plasma drug concentrations correlated with therapeutic efficacy.
Chemical Information
-
CAS No. 2848664-42-4
-
Appearance Solid
-
분자량 485.54
-
화학식 C26H27N7O3
-
Color White to off-white
-
SMILES
COC(C(C(C=C1)=NN1C)=CC(CCOCC2=NC3=CC=C2)=C4)=C4NC(C=C(N3)N=C5)=C5C(NC)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
용액&용해도
In Vitro:
DMSO : 100 mg/mL (205.96 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.15 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (281 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0596 mL | 10.2978 mL | 20.5956 mL | 51.4891 mL |
| 5 mM | 0.4119 mL | 2.0596 mL | 4.1191 mL | 10.2978 mL | |
| 10 mM | 0.2060 mL | 1.0298 mL | 2.0596 mL | 5.1489 mL | |
| 15 mM | 0.1373 mL | 0.6865 mL | 1.3730 mL | 3.4326 mL | |
| 20 mM | 0.1030 mL | 0.5149 mL | 1.0298 mL | 2.5745 mL | |
| 25 mM | 0.0824 mL | 0.4119 mL | 0.8238 mL | 2.0596 mL | |
| 30 mM | 0.0687 mL | 0.3433 mL | 0.6865 mL | 1.7163 mL | |
| 40 mM | 0.0515 mL | 0.2574 mL | 0.5149 mL | 1.2872 mL | |
| 50 mM | 0.0412 mL | 0.2060 mL | 0.4119 mL | 1.0298 mL | |
| 60 mM | 0.0343 mL | 0.1716 mL | 0.3433 mL | 0.8582 mL | |
| 80 mM | 0.0257 mL | 0.1287 mL | 0.2574 mL | 0.6436 mL | |
| 100 mM | 0.0206 mL | 0.1030 mL | 0.2060 mL | 0.5149 mL |
QL-1200186 Related Classifications
HY-156466 Related Classifications
Powered by Bioz